KD018
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KD018, covering 2019-05-22 to 2019-05-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]